Pharmacists’ Attitudes Towards Long-Term Use of Nasal Decongestants: A Cross-Sectional Study

References

• Meltzer EO, Caballero F, Fromer LM, Krouse JH. Scadding G: treatment of congestion in upper respiratory diseases. Int J Gene Med. 2010;3:69–91. doi:10.2147/ijgm.s8184
   PubMedGoogle Scholar
• Lenz D, Cardoso K, Bitti A, Andrade T. Evaluation of the use of topic nasal decongestants in university students from health sciences courses. Braz J Pharm Sci. 2011;47(4):761–767. doi:10.1590/S1984-82502011000400013
   Web of Science ®Google Scholar
• Schroer B, Pien LC. Nonallergic rhinitis: common problem, chronic symptoms. Cleveland Clin j med. 2012;79(4):285–293. doi:10.3949/ccjm.79a11099
   PubMed Web of Science ®Google Scholar
• Dykewicz MS, Wallace DV, Amrol DJ, et al. Steven GC: rhinitis 2020: a practice parameter update. J Allergy Clin Immunol. 2020;146:721–767. doi:10.1016/j.jaci.2020.07.007
   PubMed Web of Science ®Google Scholar
• Graf P. Rhinitis medicamentosa: a review of causes and treatment. Treat Respir Med. 2005;4:21–29. doi:10.2165/00151829-200504010-00003
   PubMedGoogle Scholar
• Wahid NWB, Shermetaro C. Rhinitis Medicamentosa. StatPearls. StatPearls Publishing Copyright © 2023, StatPearls Publishing LLC., Treasure Island (FL) ineligible companies; 2023. Disclosure: Carl Shermetaro declares no relevant financial relationships with ineligible companies.
   Google Scholar
• Shah R, McGrath KG. Chapter 6: nonallergic rhinitis. Allergy Asthma Proc. 2012;33(Suppl 1):19–21. doi:10.2500/aap.2012.33.3536
   PubMedGoogle Scholar
• Mortuaire G, de Gabory L, François M, et al. Rebound congestion and rhinitis medicamentosa: nasal decongestants in clinical practice. Critical review of the literature by a medical panel. Eur Ann Otorhinolaryngology. 2013;130:137–144. doi:10.1016/j.anorl.2012.09.005
   PubMed Web of Science ®Google Scholar
• Varghese M, Glaum MC, Lockey RF. Drug-induced rhinitis. Clin Exp Allergy. 2010;40(3):381–384. doi:10.1111/j.1365-2222.2009.03450.x
   PubMed Web of Science ®Google Scholar
• Huston SA, Porter KB, Clements T, Shepherd G. Pharmacists’ attitudes towards pediatric cough and cold products and behind the counter status. j Pediatric Pharmacol Therapeutics. 2010;15:126–137.
   PubMedGoogle Scholar
• Fowler J, Chin CJ, Massoud E. Rhinitis medicamentosa: a nationwide survey of Canadian otolaryngologists. J Otolaryngol. 2019;48:70. doi:10.1186/s40463-019-0392-1
   Google Scholar
• Alharthi AS, Alharthi SA, Altowairqi AF, Alswat SH, Alnofaie MF. Assessment of the Prevalence of the Use of Nasal Decongestants Among the General Population in Saudi Arabia. Cureus. 2022;14:e31892. doi:10.7759/cureus.31892
   PubMed Web of Science ®Google Scholar
• Schoenwetter WF. Allergic rhinitis: epidemiology and natural history. Allergy Asthma Proc. 2000;21(1):1–6. doi:10.2500/108854100778248971
   PubMed Web of Science ®Google Scholar
• Min YG, Kim HS, Suh SH, Jeon SY, Son YI, Yoon S. Paranasal sinusitis after long-term use of topical nasal decongestants. Acta oto-laryngologica. 1996;116(3):465–471. doi:10.3109/00016489609137874
   PubMed Web of Science ®Google Scholar
• Suh SH, Chon KM, Min YG, Jeong CH, Hong SH. Effects of topical nasal decongestants on histology of nasal respiratory mucosa in rabbits. Acta oto-laryngologica. 1995;115:664–671. doi:10.3109/00016489509139384
   PubMed Web of Science ®Google Scholar
• Shaikh N, Wald ER. Decongestants, antihistamines and nasal irrigation for acute sinusitis in children. Cochrane Database Syst Rev. 2014;2014(10):Cd007909. doi:10.1002/14651858.CD007909.pub4
   PubMedGoogle Scholar
• Lafaurie M, Olivier P, Khouri C, et al. Myocardial infarction and ischemic stroke with vasoconstrictors used as nasal decongestant for common cold: a French pharmacovigilance survey. Eur J Clin Pharmacol. 2020;76(4):603–604. doi:10.1007/s00228-019-02807-w
   PubMed Web of Science ®Google Scholar
• Grimaldi-Bensouda L, Begaud B, Benichou J, et al. Decongestant use and the risk of myocardial infarction and stroke: a case-crossover study. Sci Rep. 2021;11(1):4160. doi:10.1038/s41598-021-83718-8
   PubMedGoogle Scholar
• Stasa Petkovic IM, Djuric S, Dragutinovic N. Olivera Milovanovic: evaluation of Nasal Decongestants by Literature Review. Serb J ExpClin Res. 2019;1–7.
   Google Scholar
• Almutairi A, Almutairi H, Althwiny FA, et al. Awareness of the Unaizah populations in Al-Qassim province in Saudi Arabia regarding nasal decongestant use for allergic rhinitis and their side effect. J Family Med Primary Care. 2022;11(3):1070–1076. doi:10.4103/jfmpc.jfmpc_1258_21
   PubMedGoogle Scholar
• Alyahya AZ, Almubarak ZA, Al-Khalifah AA, Alawadh AH. Awareness of the Saudi population regarding nasal decongestants use for allergic rhinitis and their side effects. IJMDC. 2020;4:303–308. doi:10.24911/IJMDC.51-1571640524
   Google Scholar
• Javadi M, Ashrafi N, Salari P. Assessment of Pharmacists Experiences and Attitudes Toward Professionalism and its Challenges in Pharmacy Practice. Iranian j Pharm Res. 2018;17(Suppl):168–177.
   PubMedGoogle Scholar
• Svensberg K, Sporrong SK. Björnsdottir I: a review of countries’ pharmacist-patient communication legal requirements on prescription medications and alignment with practice: comparison of Nordic countries. Res Social Adm Pharm. 2015;11:784–802. doi:10.1016/j.sapharm.2015.01.002
   PubMed Web of Science ®Google Scholar
• Torquato A, Shima V, Araújo D. RISCOS ASSOCIADOS À PRÁTICA DE AUTOMEDICAÇÃO COM DESCONGESTIONANTE NASAL / RISKS ASSOCIATED WITH SELF-MEDICATION PRACTICE WITH NASAL DECONGESTANT. Braz J Dev. 2020;6(11):86899–86917. doi:10.34117/bjdv6n11-206
   Google Scholar
• Doshi J. Rhinitis medicamentosa: what an otolaryngologist needs to know. Europ Archiv Oto-Rhino-Laryngol. 2009;266(5):623–625. doi:10.1007/s00405-008-0896-1
   PubMed Web of Science ®Google Scholar
• Black MJ, Remsen KA. Rhinitis medicamentosa. Can. Med. Assoc. J. 1980;122(8):881–884.
   PubMed Web of Science ®Google Scholar
• Bende M. Treatment of Rhinitis Medicamentosa. Am J Rhinol. 1996;10(5):323–326. doi:10.2500/105065896782159639
   Google Scholar
• Segboer C, Gevorgyan A, Avdeeva K, et al. Intranasal corticosteroids for non-allergic rhinitis. Cochrane Database Syst Rev. 2019;2019.doi:10.1002/14651858.CD010592.pub2
   PubMedGoogle Scholar
• Ramey JT, Bailen E, Lockey RF. Rhinitis medicamentosa. J Invest Allergol Clin Immunol. 2006;16:148–155.
   PubMed Web of Science ®Google Scholar
• Rasheed M, Hasan S, Babar Z-U-D. Community pharmacist’s knowledge, attitude, roles and practices towards patient-centred care in Saudi Arabia: a systematic review of the literature. J Pharm Health Serv Res. 2018;10. doi:10.1111/jphs.12264
   Google Scholar
• Fisher RC. Patient education and compliance: a pharmacist’s perspective. Patient Educ Couns. 1992;19:261–271. doi:10.1016/0738-3991(92)90145-9
   PubMed Web of Science ®Google Scholar